Botanix` excessive sweat treatment Sofdra gains FDA approval
21 Jun 2024 //
FIERCE PHARMA
Botanix Pharmaceuticals in Acquisition of Sofpironium Bromide
04 May 2022 //
TROUTMAN
Brickell Biotech Announces Second U.S. Phase 3 Study of Sofpironium Bromide Gel
16 Aug 2021 //
GLOBENEWSWIRE
Brickell Biotech Announces update for Sofpironium Bromide Gel
29 Jun 2021 //
GLOBENEWSWIRE
Brickell Biotech Announces Launch Date for Sofpironium Bromide Gel, 5%
18 Nov 2020 //
GLOBENEWSWIRE
Brickell Biotech Announces Approval of Sofpironium Bromide Gel, 5% in Japan
25 Sep 2020 //
SEEKING ALPHA
Brickell Biotech Announces Issuance of Matter Patent on Sofpironium Bromide
31 Aug 2020 //
BIOSPACE
Brickell Biotech Announces Late-Breaking Oral Presentation at 2020
04 Mar 2020 //
GLOBENEWSWIRE
Brickell Biotech Announces Pub of its U.S. Ph2b Results for Sofpironium Bromide
20 Feb 2020 //
GLOBENEWSWIRE
Kaken Pharmaceutical, Submits New Drug Application for Sofpironium Bromide
10 Jan 2020 //
GLOBE NEWSWIRE
Vical finds way out of R&D woes via reverse merger
04 Jun 2019 //
ENDPTS